Cwm, LLC Entrada Therapeutics, Inc. Transaction History
Cwm, LLC
- $36.9 Billion
- Q4 2025
A detailed history of Cwm, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 2,114 shares of TRDA stock, worth $17,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,114
Previous 1,193
77.2%
Holding current value
$17,905
Previous $7,000
214.29%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TRDA
# of Institutions
119Shares Held
28MCall Options Held
13.7KPut Options Held
14K-
Baker Bros. Advisors LP New York, NY4.87MShares$41.2 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$37.1 Million56.82% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.26MShares$36.1 Million16.56% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$14.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$13.8 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $266M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...